Bioequivalence and Bioavailability Forum

From the EUFEPS website:
PQRI/EUFEPS Global Bioequivalence Harmonisation Initiative (GBHI): 6th International Workshop – GBHI 2024
April 16 – 17, 2024, Rockville, Maryland, USA

www.pqri.org • www.eufeps.org • www.fda.gov

Registration to open in fall 2023!

The 6th International Workshop – GBHI 2024 will be held on April 16–17, 2024, in Rockville, Maryland, US.
We are pleased to announce Product Quality Research Institute (PQRI) is joining the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) and the European Federation for Pharmaceutical Sciences (EUFEPS) in co-sponsoring the “6th International Workshop on Global Bioequivalence Harmonization Initiative”.
The Global Bioequivalence Harmonisation Initiative (GBHI) is intended to support the process of global harmonization via scientific discussion among international stakeholders. The first GBHI Conference, held in March 2015, and all subsequent conferences have been successful due to the active participation and presentation by speakers and participants from global academia, industry, and regulatory agencies. The GBHI workshop should be an ideal platform for scientists from the pharmaceutical industry and academia to exchange their experiences and views with the regulators and engage in active scientific discussions. The GBHI Workshop location alternates between Amsterdam, the Netherlands, and the US. The 6th GBHI Workshop will be held in the US in 2024. Global regulatory, academia and industrial speakers will be invited to the discussions.

We welcome you to attend the 6th GBHI Workshop!

---

Edit: Category changed; see also this post #1. [Helmut]